About the International Journal of Blood Transfusion
A peer-reviewed, open access platform advancing the science and practice of transfusion medicine through rigorous research, clinical excellence, and global collaboration.
Transfusion medicine requires evidence that bridges laboratory innovation with clinical application. IJBT prioritizes manuscripts that deliver actionable insights for blood centers, hospital transfusion services, regulatory agencies, and patient advocacy organizations. Our editorial board - comprising immunohematologists, transfusion specialists, hematologists, and laboratory directors - ensures that published research meets both methodological standards and practical relevance.
Each submission receives tailored review focusing on study design, analytical validity, clinical significance, and ethical compliance. Accepted articles are enriched with structured abstracts, indexed metadata, and DOI registration to support discoverability, citation tracking, and integration into evidence-based guidelines.
IJBT welcomes submissions across the full spectrum of transfusion medicine, from fundamental science to health systems implementation. Our interdisciplinary approach connects molecular biology, clinical practice, public health, and technology innovation.
Blood Banking & Collection
Donor recruitment, blood collection techniques, component preparation, processing technologies, and storage optimization.
Immunohematology
Blood group antigens, antibody detection, compatibility testing, hemolytic disease, and rare phenotype management.
Transfusion Reactions
Adverse event investigation, transfusion-related acute lung injury (TRALI), hemolytic reactions, allergic responses, and transfusion-associated circulatory overload (TACO).
Clinical Transfusion Practice
Therapeutic transfusion protocols, massive transfusion, perioperative management, neonatal/pediatric transfusion, and patient blood management.
Blood Safety & Infectious Disease
Pathogen screening, nucleic acid testing, emerging infectious risks, quarantine procedures, and safety surveillance systems.
Stem Cell & Regenerative Medicine
Hematopoietic stem cell transplantation, cord blood banking, cell therapy, and regenerative applications.
Blood Disorders & Hemotherapy
Hemophilia treatment, sickle cell disease management, thalassemia, coagulation disorders, and therapeutic apheresis.
Technology & Innovation
Automation in blood banking, point-of-care testing, digital traceability, artificial intelligence applications, and laboratory information systems.
Quality & Regulatory Affairs
Accreditation standards, regulatory compliance, quality management systems, proficiency testing, and policy development.
IJBT accepts diverse article formats to accommodate different research methodologies and communication needs. All submissions undergo rigorous peer review regardless of format.
- Original Research Articles - Innovative studies advancing transfusion science, clinical practice, or laboratory methodologies.
- Review Articles - Comprehensive syntheses of current evidence on transfusion topics, including systematic reviews and meta-analyses.
- Case Reports & Case Series - Documentation of unusual transfusion reactions, rare blood group presentations, or novel therapeutic approaches.
- Short Communications - Brief reports on preliminary findings, technical innovations, or timely observations.
- Clinical Trials & Study Protocols - Reports on interventional studies, observational research, or detailed protocol descriptions for ongoing investigations.
- Letters to the Editor - Scholarly discussions, critiques, or responses to published articles.
- Technical Notes - Descriptions of new methods, laboratory techniques, equipment modifications, or procedural improvements.
- Commentaries & Editorials - Expert perspectives on emerging issues, policy debates, or significant research developments.
- Guidelines & Best Practices - Evidence-based recommendations for clinical protocols, laboratory standards, or safety procedures.
IJBT offers flexible submission pathways designed for busy clinical and research professionals. Authors can submit manuscripts through the Online Manuscript Submission System or via email to [email protected]. Live chat support is available through the blue button on our website.
Review Instructions for Authors and ensure compliance with formatting, ethical, and reporting guidelines.
Upload manuscript, cover letter, and supplementary files through our secure submission portal with automated acknowledgment.
Expert reviewers evaluate scientific merit, methodology, and clinical relevance with constructive feedback provided to authors.
Address reviewer comments with point-by-point responses; revised manuscripts receive expedited re-review.
Accepted articles are copyedited, proofed, and published online within 2-3 days with immediate global accessibility.
IJBT's editorial board represents diverse geographic regions, institutional settings, and subspecialty expertise. Our editors ensure balanced perspectives on global transfusion challenges while maintaining rigorous quality standards.
IJBT operates on an open access model, ensuring that research findings are immediately available to clinicians, researchers, policy makers, and the public worldwide. All articles are published under Creative Commons licenses that permit unrestricted use with proper attribution.
As a self-supporting journal, IJBT relies on article processing charges (APCs) to cover peer review management, editorial operations, hosting infrastructure, and indexing services. Fees are assessed only after manuscript acceptance, and waivers or discounts may be available for authors from low-income countries or institutions with financial constraints.
